Philipps-Universität Marburg, Department of Pharmaceutics and Biopharmacy, Ketzerbach 63, 35032, Marburg, Germany.
Lab Chip. 2012 Jul 21;12(14):2498-506. doi: 10.1039/c2lc40176b. Epub 2012 May 3.
Poly(ethylene imine) (PEI) is an established non-viral vector system for the delivery of various nucleic acids in gene therapy applications. Polyelectrolyte complexes between both compounds, so called polyplexes, are formed by electrostatic interactions of oppositely charged macromolecules and are thought to facilitate uptake into cells. Such complexes form spontaneously and on lab scale they are usually prepared by mixing solutions through pipetting. Hence, an optimized preparation procedure allowing the scale-up of well-defined polyplexes would be of general interest. We developed a new method for microfluidic polyplex preparation on a chip. The mixing behaviour within the microfluidic channels was evaluated. Polyplexes with PEI and plasmid DNA were prepared using this method, in comparison to the standard pipetting procedure. Sizes and polydispersity indices of these complexes were examined. The influence of various parameters on the polyplex characteristics and the suitability of this production procedure for other PEI-based complexes were also evaluated. It was shown that polyplexes could easily be prepared by microfluidics. The ratio of PEI to DNA was most important for the formation of small polyplexes, whereas other parameters had minor influence. The size of polyplexes prepared with this new method was observed to be relatively constant between 140 nm and 160 nm over a wide range of complex concentrations. In comparison, the size of polyplexes prepared by pipetting (approximately 90 nm to 160 nm) varied considerably. The versatility of this system was demonstrated with different (targeted) PEI-based vectors for the formation of complexes with pDNA and siRNA. In conclusion, polyplex preparation using microfluidics could be a promising alternative to the standard pipetting method due to its suitability for preparation of well-defined complexes with different compositions over a wide range of concentrations.
聚乙烯亚胺(PEI)是一种已确立的非病毒载体系统,可用于基因治疗应用中各种核酸的递送。这两种化合物之间的聚电解质复合物,即所谓的聚合物,是通过带相反电荷的大分子之间的静电相互作用形成的,被认为有助于细胞摄取。这些复合物会自发形成,在实验室规模上,它们通常通过移液器混合溶液来制备。因此,开发一种允许大规模制备定义明确的聚合物的优化制备程序将具有普遍意义。我们开发了一种在芯片上进行微流控聚合物制备的新方法。评估了微流道内的混合行为。使用该方法制备了 PEI 和质粒 DNA 的聚合物,与标准移液器程序进行了比较。检查了这些复合物的大小和多分散指数。还评估了各种参数对聚合物特性的影响以及该生产程序对其他基于 PEI 的复合物的适用性。结果表明,微流控技术可轻松制备聚合物。PEI 与 DNA 的比例对于形成小聚合物至关重要,而其他参数的影响较小。与通过微流控技术制备的新方法相比,通过移液器制备的聚合物的尺寸(约 90nm 至 160nm)变化很大。通过使用不同的(靶向)基于 PEI 的载体来形成与 pDNA 和 siRNA 的复合物,证明了该系统的多功能性。总之,由于其适合在广泛的浓度范围内制备具有不同组成的定义明确的复合物,因此使用微流控技术制备聚合物可能是标准移液器方法的有前途的替代方法。